Share ownership Pfizer Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - NYSE Other stock markets 21:01:55 09/06/2026 BST			5-day change	1st Jan Change
25.70 ^USD	+0.31%		+0.27%	+3.21%

06-09	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
06-08	AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials	DJ

Share class: Pfizer Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,641,444,169	5,693,711,442 ( 59.05 %)	3,942,000,000 ( 40.89 %)	59.05 %

Major shareholders: Pfizer Inc.

Name	Stocks	%	Valuation
Vanguard Capital Management LLC 6.482 %	369,430,012	6.482 %	9 672 M $
BlackRock Advisors LLC 6.257 %	356,638,574	6.257 %	9 337 M $
STATE STREET CORPORATION 5.292 %	301,589,865	5.292 %	7 896 M $
Geode Capital Management LLC 2.343 %	133,561,742	2.343 %	3 497 M $
Ishares (DE) InvAG mit Teilgesellschaftsvermogen 2.267 %	129,224,225	2.267 %	3 383 M $
Vanguard Portfolio Management LLC 2.048 %	116,734,695	2.048 %	3 056 M $
Fisher Asset Management LLC 1.842 %	104,964,427	1.842 %	2 748 M $
Eaton Vance Management 1.626 %	92,685,370	1.626 %	2 427 M $
Norges Bank (13F) 1.29 %	73,533,577	1.29 %	1 925 M $
Vanguard Fiduciary Trust Co. 1.038 %	59,180,489	1.038 %	1 549 M $
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Stocks	%	Valuation
Caixa DTVM SA 0.001021 %	232,792	0.001021 %	2 M $
Itaú Unibanco Asset Management Ltda. 0.001015 %	231,510	0.001015 %	2 M $
Morgan Stanley Administradora de Carteiras SA 0.000061 %	13,826	0.000061 %	89 764 $

Breakdown by shareholder type

Institutional	52.71%
Others	8.18%
State Street Corp.	5.29%
Schweizerische Nationalbank	0.29%
Sumitomo Mitsui Trust Group, Inc.	0.25%
Governments	0.16%
Swedbank AB	0.11%
The Bank of Nova Scotia	0.09%
Fifth Third Bancorp	0.08%
SEI Investments Co.	0.08%
Manulife Financial Corp.	0.06%
Danske Bank A/S	0.06%
Clal Insurance Enterprises Holdings Ltd.	0.04%
Old Republic International Corp.	0.03%
Peapack-Gladstone Financial Corp.	0.02%
Individuals	0.02%
Banco Bilbao Vizcaya Argentaria SA	0.02%
Fairfax Financial Holdings Ltd.	0.02%
Zurich Insurance Group AG	0.02%
Zions Bancorporation NA	0.01%
First Horizon Corp. (Tennessee)	0.01%
First Financial Bankshares, Inc.	0.01%
Intesa Sanpaolo SpA	0.01%
Pinnacle Financial Partners, Inc.	0.01%
Commerzbank AG	0.01%
Rathbones Group Plc	0.01%
The Allstate Corp.	0.01%
ING Groep NV	0.01%
Ally Financial, Inc.	0.01%
Unknown	32.37%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	48.93%
United Kingdom	4.71%
Canada	3.15%
Germany	2.56%
Norway	1.51%
France	0.97%
Switzerland	0.93%
Australia	0.83%
Japan	0.73%
Sweden	0.49%
Netherlands	0.33%
Denmark	0.32%
Hong Kong	0.31%
Liechtenstein	0.31%
South Korea	0.3%
Luxembourg	0.18%
Belgium	0.17%
Ireland	0.16%
Cayman Islands	0.11%
Italy	0.1%
Portugal	0.07%
Spain	0.07%
Finland	0.07%
Taiwan	0.05%
Israel	0.05%
New Zealand	0.04%
Czech Republic	0.03%
Singapore	0.03%
Russia	0.02%
Austria	0.02%
Individuals	0.02%
Saudi Arabia	0.01%
Slovenia	0.01%
China	0.01%
Brazil	0.01%
South Africa	0.01%

Based on 1000 largest holdings

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.

Employees

75,000

Sector

Pharmaceuticals

More about the company